Unlike many peptides that have only injectable research data, GHK-Cu has been tested in published human clinical trials specifically as a topical application with outcomes that compared favorably against gold-standard actives
See Homocysteine and Mild B12 Deficiency in Vegans for more info
Research Background In preclinical (animal and in vitro) models, BPC-157 has been studied as a cytoprotective peptide of interest in gastrointestinal, musculoskeletal, and vascular research
This targeted administration allows for rapid absorption and utilization by the body
Advantages of Matrixyl (Palmitoyl Pentapeptide-4): Good cosmetic efficacy data, lipophilic for skin penetration
People with chronic inflammation, autoimmune diseases, or pain syndromes often report significant improvements without harsh medication